Impact of probiotics on inflammatory bowel disease - a systematic review
DOI:
https://doi.org/10.12775/JEHS.2024.57.004Keywords
probiotics, inflammatory bowel disease, Crohn’s disease, ulcerative colitisAbstract
Introduction: Inflammatory bowel disease (IBD) is a chronic nonspecific inflammatory disease of the gastrointestinal tract that includes ulcerative colitis (UC) and Crohn's disease (CD). Both disease entities have many features in common, such as a basis of chronic inflammation, similar clinical symptoms as well as periods of remission and relapse. The difference between them lies in the lesions location. Treatment of IBD is primarily based on reducing inflammation and maintaining as long a remission time as possible. Increasing evidence is being attributed to the therapeutic potential of probiotics in IBD.
Purpose: This review aims to present the preventive and therapeutic effects of probiotic use in IBS through an analysis of recent studies.
Methods: A review of recent literature was conducted to investigate the impact of probiotic use on the treatment of IBD.
Results: In studies, probiotics help induce and maintain remission in patients with mild to moderate ulcerative colitis, especially when used in combination therapy. In contrast, the usage of probiotics in Crohn's disease does not provide due benefit: it does not induce or prolong remission.
Conclusions: In conclusion, the effect of probiotics on IBD is inconclusive. Some probiotics, particularly the VSL#3 probiotic blend, have shown decent effects on induction and remission in patients with mild to moderate UC. However, no therapeutic effect has been demonstrated in patients with Crohn's Disease. Therefore studies under more restrictive and standardized conditions are required.
References
Vakadaris, G.; Stefanis, C.; Giorgi, E.; Brouvalis, M.; Voidarou, C.; Kourkoutas, Y.; Tsigalou, C.; Bezirtzoglou, E. The Role of Probiotics in Inducing and Maintaining Remission in Crohn’s Disease and Ulcerative Colitis: A Systematic Review of the Literature. Biomedicines 2023, 11, 494. https://doi.org/10.3390/ biomedicines11020494
Li, C., Peng, K., Xiao, S. et al. The role of Lactobacillus in inflammatory bowel disease: from actualities to prospects. Cell Death Discov. 9, 361 (2023). https://doi.org/10.1038/s41420-023-01666-w
Dominika Jakubczyk, Katarzyna Leszczyńska and Sabina Górska The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review Nutrients 2020, 12(7), 1973; https://doi.org/10.3390/nu12071973
Pavel, F.M.; Vesa, C.M.; Gheorghe, G.; Diaconu, C.C.; Stoicescu, M.; Munteanu, M.A.; Babes, E.E.; Tit, D.M.; Toma, M.M.; Bungau, S. Highlighting the Relevance of Gut Microbiota Manipulation in Inflammatory Bowel Disease. Diagnostics 2021, 11, 1090. https:// doi.org/10.3390/diagnostics11061090
Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics? Amélie Lê, Marine Mantel, Justine Marchix, Marie Bodinier, Gwénaël Jan, and Malvyne Rolli-Derkinderen16 NOV 2022 https://doi.org/10.1152/ajpgi.00002.2022
Caitlyn Hsu, Mahmoud Ghannoum, Fabio Cominelli, Luca Di Martino, Mycobiome and Inflammatory Bowel Disease: Role in Disease Pathogenesis, Current Approaches and Novel Nutritional-based Therapies, Inflammatory Bowel Diseases, Volume 29, Issue 3, March 2023, Pages 470–479, https://doi.org/10.1093/ibd/izac156
Complementary and alternative medications in the management of inflammatory bowel disease Sherman Picardo, Mansour Altuwaijri, Shane M. Devlin and Cynthia H. Seow Ther Adv Gastroenterol 2020, Vol. 13: 1–15 DOI: 10.1177/ 1756284820927550
Lopes, S.A.; Roque-Borda, C.A.; Duarte, J.L.; Di Filippo, L.D.; Borges Cardoso, V.M.; Pavan, F.R.; Chorilli, M.; Meneguin, A.B. Delivery Strategies of Probiotics from Nanoand Microparticles: Trends in the Treatment of Inflammatory Bowel Disease—An Overview. Pharmaceutics 2023, 15, 2600. https://doi.org/10.3390/ pharmaceutics15112600
Hu, Y.; Chen, Z.; Xu, C.; Kan, S.; Chen, D. Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease. Nutrients 2022, 14, 5140. https://doi.org/10.3390/ nu14235140
Zhu, M.; Song, Y.; Xu, Y.; Xu, H. Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored. Int. J. Mol. Sci. 2023, 24, 11004. https:// doi.org/10.3390/ijms241311004
: Haneishi, Y.; Furuya, Y.; Hasegawa, M.; Picarelli, A.; Rossi, M.; Miyamoto, J. Inflammatory Bowel Diseases and Gut Microbiota. Int. J. Mol. Sci. 2023, 24, 3817. https:// doi.org/10.3390/ijms24043817
Gopal S. Palandurkar , Sunil Kuma Biofilm's Impact on Inflammatory Bowel Diseases DOI: 10.7759/cureus.45510
Himani Pandey, Dheeraj Jain, Daryl W. T. Tang, Sunny H. Wong, Devi Lal, Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease Intestinal Research 2023;ir.2023.00080 DOI: https://doi.org/10.5217/ir.2023.00080
Shuo Yuan,Ke-Si Wang,Huan Meng,Xiao-Ting Hou,Jia-Chen Xue,Bao-Hong Liu,Wen-Wen Cheng,Jiao Li,Hua-Min Zhang,Ji-Xing Nan,Qing-Gao Zhang The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy Biomedicine & Pharmacotherapy, September 2023 https://doi.org/10.1016/j.biopha.2023.114893
Roy S, Dhaneshwar S. Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives. World J Gastroenterol 2023; 29(14): 2078-2100 DOI: https://dx.doi.org/10.3748/wjg.v29.i14.2078
Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M and Francavilla R (2021) Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body. Front. Immunol. 12:578386. doi: 10.3389/fimmu.2021.578386
Alejandro Cabezas-Cruz Luis G. Bermúdez-Humarán Exploring the relationship between Faecalibacterium duncaniae and Escherichia coli in inflammatory bowel disease (IBD): insights and implications Published: November 18, 2023 DOI:https://doi.org/10.1016/j.csbj.2023.11.027
Akutko, K.; Stawarski, A. Probiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases. J. Clin. Med. 2021, 10, 2466. https://doi.org/10.3390/jcm10112466
Lorentz A, Müller L. Probiotics in the Treatment of Inflammatory Bowel Disease in Adulthood: A Systematic Review. JGLD. 19Mar.2022 ;31(1):74-. DOI: http://dx.doi.org/10.15403/jgld-3936
Abraham, B., and Quigley, E. (2020). Antibiotics and probiotics in inflammatory bowel disease: when to use them? Frontline Gastroenterol. 11, 62–69. doi: 10.1136/ flgastro-2018-101057
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health Paulina Markowiak, Katarzyna Śliżewska, Nutrients 2017, 9(9), 1021; https://doi.org/10.3390/nu9091021
Dong LN, Wang M, Guo J, et al. Role of intestinal microbiota and metabolites in inflammatory bowel disease. Chin Med J (Engl). 2019;132:1610–4. DOI: 10.1097/CM9.0000000000000290
Tsai, YL., Lin, TL., Chang, CJ. et al. Probiotics, prebiotics and amelioration of diseases. J Biomed Sci 26, 3 (2019). https://doi.org/10.1186/s12929-018-0493-6
Martyniak, A.; Medyńska-Przęczek, A.; Wędrychowicz, A.; Skoczeń S.; Tomasik, P.J. Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD. Biomolecules 2021, 11, 1903. https://doi.org/10.3390/biom11121903
Zheng L, Wen XL. Gut microbiota and inflammatory bowel disease: The current status and perspectives. World J Clin Cases 2021; 9(2): 321-333 DOI: https://dx.doi.org/10.12998/wjcc.v9.i2.321
Toumi, R.; Samer, A.; Soufli, I.; Rafa, H.; Touil-Boukoffa, C. Role of Probiotics and Their Metabolites in Inflammatory Bowel Diseases (IBDs). Gastroenterol. Insights 2021, 12, 56–66. https://doi.org/10.3390/gastroent12010006
Jadhav A, Jagtap S, Vyavahare S, Sharbidre A, Kunchiraman B. Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis. Front Cell Infect Microbiol. 2023 Dec 8;13:1268041. doi: 10.3389/fcimb.2023.1268041. PMID: 38145046; PMCID: PMC10739422.
Świrkosz G, Szczygieł A, Logoń K, Wrześniewska M, Gomułka K. The Role of the Microbiome in the Pathogenesis and Treatment of Ulcerative Colitis-A Literature Review. Biomedicines. 2023 Nov 25;11(12):3144. doi: 10.3390/biomedicines11123144. PMID: 38137365; PMCID: PMC10740415.
Mitra AK, Asala AF, Malone S, Mridha MK. Effects of Probiotics in Adults with Gastroenteritis: A Systematic Review and Meta-Analysis of Clinical Trials. Diseases. 2023 Oct 11;11(4):138. doi: 10.3390/diseases11040138. PMID: 37873782; PMCID: PMC10594472.
Li, Q.; Zheng, T.; Ding, H.; Chen, J.; Li, B.; Zhang, Q.; Yang, S.; Zhang, S.; Guan, W. Exploring the Benefits of Probiotics in Gut Inflammation and Diarrhea—From an Antioxidant Perspective. Antioxidants 2023, 12, 1342. https://doi.org/10.3390/antiox12071342
Derwa , Y.; Gracie, D.J.; Hamlin, P.J.; Ford, A.C. Systematic review with meta-analysis: The efficacy of probiotics in inflammatory bowel disease. Aliment. Pharmacol. Ther. 2017, 46, 389–400 https://doi.org/10.1111/apt.14203
Cai Z, Wang S and Li J (2021) Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front. Med. 8:765474. doi: 10.3389/fmed.2021.765474
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Justyna Fijałkowska, Maciej Pełka, Anna Kania, Łukasz Ciulkiewicz
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 396
Number of citations: 0
